Story hasn't changed. hang in there longs.
not good at technical speak...below is taken from astx website, under technologies...as they expand on "provides significant diagnostic...
" Astex is recognized as a leader in fragment-based drug discovery, one of the most significant advances in the last 20 years.
Starts with very small, low molecular weight drug fragments
These fragments have the potential to keep the overall complexity and molecular weight of each drug candidate low
These are key factors in successful drug development"
the latest presentation was of course forward looking, but they offered detailed assessments of the discoveries and dead ends. personally, i say hats off to the crew that came up with sgi-110...the facts show they have a break-through in disrupting the defense structure of tumors. it appears to have a range of efficacy that has yet to be discovered. and that is only one of two forward looking prospects.
I think you missed something: 16 April 2013
Also: and now value Astex at $678m (including cash), equivalent to $7.25 per share basic or $6.24 per share (fully diluted). They stock was trading at a little under $7 before it fell off a cliff the begining of May.
My pleasure. This company has plenty of value drivers, plenty of cash. Little over-done on the pullback, but then again, the run-up was high. I'm a long with 10K shares at an average cost at $5.70 and not at all worried. Read the transcript from the latest UBS conference and you'll have greater comfort that you're in the right stock. I'm in this stock for the long haul and believe management is making the right moves. Will be oversold very soon and then it's a rise and stabilizing into the mid-$5s. Shorts will eventually close out their positions and value seekers will discover and/or re-visit ASTX.
I also like TSRX, btw, having initiated a position today.
Sentiment: Strong Buy